{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:50:53Z","timestamp":1790610653462,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2022SK2025"],"award-info":[{"award-number":["2022SK2025"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["BJ202003"],"award-info":[{"award-number":["BJ202003"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071986"],"award-info":[{"award-number":["82071986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372072"],"award-info":[{"award-number":["82372072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.148223","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:11:58Z","timestamp":1760001118000},"page":"148223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["The role of solute carrier family 16 member 3 protein in hepatocellular carcinoma and sorafenib resistance"],"prefix":"10.1016","volume":"330","author":[{"given":"Xiaopei","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.148223_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family - structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0010","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","article-title":"Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics?","volume":"90","author":"Singh","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216824","article-title":"Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming","volume":"589","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0030","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","article-title":"MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma","volume":"41","author":"Qian","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0040","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0055","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.2147\/OTT.S212465","article-title":"The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells","volume":"12","author":"Wang","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100788","article-title":"Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis","volume":"28","author":"Deng","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0065","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib","volume":"150","author":"Zhou","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41416-019-0482-x","article-title":"M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma","volume":"121","author":"Dong","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114798","article-title":"Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma","volume":"163","author":"Wei","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0080","article-title":"Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0085","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jshs.2020.02.006","article-title":"The tortuous path of lactate shuttle discovery: From cinders and boards to the lab and ICU","volume":"9","author":"Brooks","year":"2020","journal-title":"J. Sport Health Sci."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The science and translation of lactate shuttle theory","volume":"27","author":"Brooks","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0095","article-title":"Lactylation and HCC progression","author":"Kotsiliti","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","article-title":"Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.02.013","article-title":"Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease","volume":"34","author":"Pan","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0115","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/tox.24014","article-title":"SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A-mediated SLC7A11 expression and promoting aerobic glycolysis","volume":"39","author":"Li","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0140","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/s12276-022-00878-x","article-title":"Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy","volume":"54","author":"Zhou","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13046-020-01768-8","article-title":"Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis","volume":"39","author":"Wu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156094","article-title":"A multi-omic analysis reveals that Gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1","volume":"135","author":"Zheng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012118","article-title":"CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinoma","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0160","article-title":"Tribbles pseudokinase 3 converts sorafenib therapy to neutrophil-mediated lung metastasis in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109223","article-title":"Therapeutic efficacy of nivolumab plus sorafenib therapy in patients with unresectable hepatocellular carcinoma","volume":"112","author":"Peng","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12885-022-09173-4","article-title":"Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0180","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1093\/oncolo\/oyad113","article-title":"Association of tumor cell metabolic subtype and immune response with the clinical course of hepatocellular carcinoma","volume":"28","author":"Wei","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103016","article-title":"M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0190","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acsnano.3c05847","article-title":"Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles","volume":"18","author":"Pei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0195","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/s41467-025-61112-6","article-title":"Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of \u03b2-catenin","volume":"16","author":"Yan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1515\/oncologie-2024-0667","article-title":"AKR1C3 promotes bile acid production and contributes to the occurrence and development of liver cancer by upregulating HMG-CoA reductase","volume":"27","author":"Wang","year":"2025","journal-title":"Oncologie"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0205","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1167\/iovs.18-23892","article-title":"Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization","volume":"59","author":"Song","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12935-023-03172-6","article-title":"PDGF-BB accelerates TSCC via fibroblast lactates limiting miR-26a-5p and boosting mitophagy","volume":"24","author":"Xu","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2025.148223_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12673","article-title":"Inhibition of CREB-mediated ZO-1 and activation of NF-\u03baB-induced IL-6 by colonic epithelial MCT4 destroys intestinal barrier function","volume":"52","author":"Zhang","year":"2019","journal-title":"Cell Prolif."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302508780X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302508780X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:50:56Z","timestamp":1781743856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302508780X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"alternative-id":["S014181302508780X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148223","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of solute carrier family 16 member 3 protein in hepatocellular carcinoma and sorafenib resistance","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148223"}}